- UPSpace Home
- →
- Workspace (UPSpace)
- →
- Browsing Workspace (UPSpace) by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Workspace (UPSpace) by Author "Ebenhan, Thomas"
Now showing items 1-4 of 4
-
Le Roux, Jannie; Rubow, Sietske; Ebenhan, Thomas (Elsevier, 2021-02)Gallium-68 labelled 1,4,7-triazacyclononane-1,4,7-triacetic acid ubiquicidin (NOTA-UBI) is currently investigated as a PET radiopharmaceutical for the imaging of infections. The aim of this study was to compare the labelling ...
-
Kleynhans, Janke; Sathekge, Mike Machaba; Ebenhan, Thomas (MDPI, 2021-08-24)The rationale for application of nanotechnology in targeted alpha therapy (TAT) is sound. However, the translational strategy requires attention. Formulation of TAT in nanoparticulate drug delivery systems has the potential ...
-
Bolcaen, Julie; Kleynhans, Janke; Nair, Shankari; Verhoeven, Jeroen; Goethals, Ingeborg; Sathekge, Mike Machaba; Vandevoorde, Charlot; Ebenhan, Thomas (Ivyspring International Publisher, 2021-07-06)Despite numerous clinical trials and pre-clinical developments, the treatment of glioblastoma (GB) remains a challenge. The current survival rate of GB averages one year, even with an optimal standard of care. However, the ...
-
Everix, Liesbeth; Nair, Shankari; Driver, Cathryn H. S.; Goethals, Ingeborg; Sathekge, Mike Machaba; Ebenhan, Thomas; Vandevoorde, Charlot; Bolcaen, Julie (MDPI, 2022-04-03)Despite numerous innovative treatment strategies, the treatment of glioblastoma (GB) remains challenging. With the current state-of-the-art therapy, most GB patients succumb after about a year. In the evolution of ...
Now showing items 1-4 of 4